FDA

[biomanbaba]

I like GERN for a lot of reasons.......most importantly whats happening in this story:
http://www.geron.com/media/pressview.aspx?id=1195
they are a long way from any FDA approval.......but they already command a high price relative to biotech in their stage of developement........why? Check out the balance sheet...they have a cash hoard to die for. Most believe their cash can get them to FDA without further dilution

Their treatment for spinal cord injury may not follow the normal course of developement..........If patients in a phase II trial get up and walk....the media attn that will draw will by enormous
http://seekingalpha.com/article/142880-geron-s-risk-reward-profile-best-in-biotech